李 仁傑

Medicine & Life Sciences

1. Clostridium difficile 85%
2. Clostridium Infections 71%
3. Infections 46%
4. Metronidazole 39%
5. Ribotyping 30%
6. Intensive Care Units 29%
7. Vancomycin 25%
8. Tigecycline 23%
9. Multicenter Studies 22%
10. Doxycycline 19%
11. Probiotics 18%
12. Odds Ratio 17%
13. Coronavirus 14%
14. Monkeypox 14%
15. Length of Stay 14%
16. Clostridium butyricum 14%
17. Pulmonary Aspergillosis 13%
18. Antiviral Agents 13%
19. Proton Pump Inhibitors 13%
20. Azoles 13%
21. Neurospora 13%
22. Colitis 13%
23. Dengue 12%
24. NLR Proteins 12%
25. Mortality 12%
26. Candidemia 11%
27. Hospitalization 11%
28. Coinfection 11%
29. Anti-Bacterial Agents 11%
30. Dysbiosis 10%
31. Clostridium 10%
32. Therapeutics 10%
33. Partial Thromboplastin Time 10%
34. Carbapenems 9%
35. Diabetes Mellitus 9%
36. Human Influenza 9%
37. Bacteremia 9%
38. Enterobacteriaceae 9%
39. Hospital Mortality 9%
40. Toll-Like Receptors 9%
41. Infection Control 9%